Robitussin Buyers' Lack Of Receipts Dooms Labeling Cert.

By Henrik Nilsson · March 22, 2024, 10:57 PM EDT

A New York federal judge on Thursday denied class certification in litigation claiming GlaxoSmithKline lied about the "Maximum Strength" label on certain Robitussin cough syrup products, saying although the plaintiffs' lack...

To view the full article, register now.

Documents

Case Information

Case Title

Woodhams et al v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.

Case Number

1:18-cv-03990

Court

New York Southern

Nature of Suit

Contract: Other

Date Filed

May 03, 2018